par Luc St-Pierre | Sep 19, 2022 | Non classé
Algernon Pharmaceuticals Files for Orphan Designation with the U.S. FDA for Ifenprodil as a Treatment of IPF VANCOUVER, British Columbia, Sept. 19, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT:...
par Luc St-Pierre | Sep 16, 2022 | Non classé
Hemostemix Announces the Appointment of Dr. Nadia Giannetti, MD, to its Scientific Advisory Board Calgary, Alberta–(Newsfile Corp. – September 16, 2022) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (« Hemostemix » or the « Company ») is...
par Luc St-Pierre | Sep 15, 2022 | Non classé
Hemostemix Announces the Appointment of Dr. Johannes Grillari to its Scientific Advisory Board Calgary, Alberta–(Newsfile Corp. – September 15, 2022) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (« Hemostemix » or the « Company ») is pleased to...
par Luc St-Pierre | Sep 14, 2022 | Non classé
Troilus Shortlisted For AEMQ’s « Entrepreneur Of The Year » Award MONTREAL, Sept. 14, 2022 (GLOBE NEWSWIRE) — Troilus Gold Corp. (« Troilus » or the « Company ») (TSX: TLG; OTCQX: CHXMF) is honoured to have been named one of three finalists for the Quebec...
par Luc St-Pierre | Sep 14, 2022 | Non classé
Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board Calgary, Alberta–(Newsfile Corp. – September 14, 2022) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (« Hemostemix » or the « Company ») is pleased to...
par Luc St-Pierre | Sep 14, 2022 | Non classé
Canada Silver Cobalt Completes Commissioning of High-Grade Processing and Gravity Plants at TTL Facility TTL is now ready to process high-grade mineralized material and tailings from nearby mines into silver dore bars. Coquitlam, BC – TheNewswire –...
